Analyst Ratings for Design Therapeutics Inc (DSGN)
DSGN Rating Summary
DSGN Price Target Summary
- Highest: $18.00 (Oppenheimer)
- Lowest: $13.00 (RBC Capital)
- Average: $15.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.00 (+49.3%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
Avg. $ Target:
$15.00 (+49.3%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/7/2026 | Oppenheimer | Kostas Biliouris | New Coverage | Outperform (N/A) |
18.00 (N/A) |
8.82 (10.05) |
13.95% | Details |
| 12/3/2025 | Craig-Hallum | Adam Vogel | New Coverage | Buy (N/A) |
15.00 (N/A) |
8.94 (10.05) |
12.42% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
